Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02156518
Other study ID # 2014-027
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 2014
Est. completion date March 2018

Study information

Verified date May 2018
Source University of Kentucky
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine if the systematic practice of Vocal Function Exercises (VFE) improves selected measures of voice production in participants who have previously been irradiated for early glottic cancers compared to participants who receive the present standard of care, namely, vocal hygiene counseling. It is hypothesized that a prescriptive vocal exercise program (VFE) will improve the voice production of individuals who have been previously treated for laryngeal cancers when compared to participants who receive vocal hygiene alone.


Recruitment information / eligibility

Status Completed
Enrollment 12
Est. completion date March 2018
Est. primary completion date January 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Hearing level and cognitive ability to follow test directions

- Laryngeal cancer

- Radiation Therapy completed >= 6 months

- Deemed disease free by the treating physician

- Subjects have to be willing to attend weekly voice therapy sessions

Exclusion Criteria:

- Adjuvant treatment: laser or any surgical intervention

- Neurological or cognitive impairment

- Hearing levels that interfere with following test instruction

- Vocal fold paralysis

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Vocal Function Exercises
Vocal Function Exercises
Vocal Hygiene
Vocal Hygiene

Locations

Country Name City State
United States University of Kentucky Lexington Kentucky
United States University of Kentucky, Markey Cancer Center Lexington Kentucky

Sponsors (1)

Lead Sponsor Collaborator
Vrushali Angadi

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Voice production Voice Handicap Index, a validated self- assessment tool was used as the primary outcome measure. A score of 0 indicates no handicap, and a score of 120 indicates complete impairment. Data will be presented as pre and post treatment score (pre and post 6 weeks of therapy). 6 weeks